cellular activation signaling elisa kit jnk t183/y185 (SuperArray Bioscience Corporation)
90
Structured Review
SuperArray Bioscience Corporation
cellular activation signaling elisa kit jnk t183/y185
Cellular Activation Signaling Elisa Kit Jnk T183/Y185, supplied by SuperArray Bioscience Corporation, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/cellular+activation+of+signalling+elisa+kits+jnk/cellular+activation+signaling+elisa+kit+jnk+t183+y185/pmc03423103-220-17-19
Average 90 stars, based on 1 article reviews
Cellular Activation Signaling Elisa Kit Jnk T183/Y185, supplied by SuperArray Bioscience Corporation, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/cellular+activation+of+signalling+elisa+kits+jnk/cellular+activation+signaling+elisa+kit+jnk+t183+y185/pmc03423103-220-17-19
Average 90 stars, based on 1 article reviews
cellular activation signaling elisa kit jnk t183/y185 - by Bioz Stars,
2026-10
90/100 stars
Images
Related Articles
Transduction:Article Title: Modulation of telomerase and signal transduction proteins by hexyl-ALA-photodynamic therapy (PDT) in human doxorubicin resistant cancer cell models. Article Snippet: Photodiagnosis and Photodynamic Therapy (2012) 9, 243—255 Available online at www.sciencedirect.com journa l h o m epage: www.elsev ier .com/ locate /pdpdt Modulation of telomerase and signal transduction proteins by Hexyl-ALA-Photodynamic Therapy (PDT) in human doxorubicin resistant cancer cell models Ellie S.M.. Chu, Christine M.N.. Yow PhD ∗ Medical Laboratory Science Section, Department of Health Technology & Informatics, The Hong Kong Polytechnic University, Hong Kong Special Administrative Region Available online 28 January 2012 KEYWORDS Photodynamic therapy; Hexyl-ALA; Drug resistance; MAPK; Telomerase; Uterine sarcoma Summary Aims: This study employed a doxorubicin resistant (MES-SA-Dx5) human uterine sarcoma cell line and its counterpart (MES-SA), to elucidate the efficacy of aminolevulinic acid-hexylester (hexyl-ALA) mediated PDT at molecular and transcriptional levels. Activation Assay:Article Title: Modulation of telomerase and signal transduction proteins by hexyl-ALA-photodynamic therapy (PDT) in human doxorubicin resistant cancer cell models. Article Snippet: Photodiagnosis and Photodynamic Therapy (2012) 9, 243—255 Available online at www.sciencedirect.com journa l h o m epage: www.elsev ier .com/ locate /pdpdt Modulation of telomerase and signal transduction proteins by Hexyl-ALA-Photodynamic Therapy (PDT) in human doxorubicin resistant cancer cell models Ellie S.M.. Chu, Christine M.N.. Yow PhD ∗ Medical Laboratory Science Section, Department of Health Technology & Informatics, The Hong Kong Polytechnic University, Hong Kong Special Administrative Region Available online 28 January 2012 KEYWORDS Photodynamic therapy; Hexyl-ALA; Drug resistance; MAPK; Telomerase; Uterine sarcoma Summary Aims: This study employed a doxorubicin resistant (MES-SA-Dx5) human uterine sarcoma cell line and its counterpart (MES-SA), to elucidate the efficacy of aminolevulinic acid-hexylester (hexyl-ALA) mediated PDT at molecular and transcriptional levels. Enzyme-linked Immunosorbent Assay:Article Title: Modulation of telomerase and signal transduction proteins by hexyl-ALA-photodynamic therapy (PDT) in human doxorubicin resistant cancer cell models. Article Snippet: Photodiagnosis and Photodynamic Therapy (2012) 9, 243—255 Available online at www.sciencedirect.com journa l h o m epage: www.elsev ier .com/ locate /pdpdt Modulation of telomerase and signal transduction proteins by Hexyl-ALA-Photodynamic Therapy (PDT) in human doxorubicin resistant cancer cell models Ellie S.M.. Chu, Christine M.N.. Yow PhD ∗ Medical Laboratory Science Section, Department of Health Technology & Informatics, The Hong Kong Polytechnic University, Hong Kong Special Administrative Region Available online 28 January 2012 KEYWORDS Photodynamic therapy; Hexyl-ALA; Drug resistance; MAPK; Telomerase; Uterine sarcoma Summary Aims: This study employed a doxorubicin resistant (MES-SA-Dx5) human uterine sarcoma cell line and its counterpart (MES-SA), to elucidate the efficacy of aminolevulinic acid-hexylester (hexyl-ALA) mediated PDT at molecular and transcriptional levels. |